glp-1 dementia news Adults whose type 2 diabetes was treated with receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective GLP-1 drugs failed to slow

those with slow metabolism

3 Expert Rev Clin Pharmacol Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria (Minder & Schneider-Yin, 2014)Reviews the -MSH receptor-mediated mechanism, the rationale for afamelanotide in protoporphyria, and the phase II/III and safety results, concluding the risk-benefit profile is favorable in this indication

( Epub 2017/08/07 )

Following these experiences during COVID, the European Commission planned to increase support for drug repurposing to search for treatments for cancer

Alpha-tocopherol is believed to be the first part of an antioxidant network (shown below) where it is oxidized to donate an electron to stabilize reactive oxygen species